Archie Lovatt
Papers
1
Total Citations
63
H-Index
1
About
Archie Lovatt is a leading figure in the biosafety and quality control of biotechnology products, with a specialized focus on the application of quantitative PCR (qPCR) for genetic stability assessment. His seminal 2002 paper, "Applications of quantitative PCR in the biosafety and genetic stability assessment of biotechnology products," has garnered 63 citations, establishing a foundational methodology for the field. Lovatt's work has been instrumental in developing rigorous, molecular-based approaches to ensure the safety and consistency of genetically modified organisms and biopharmaceuticals. By adapting qPCR for precise detection of genetic alterations, he provided the industry with a critical tool for regulatory compliance and product validation. His contributions have directly influenced how biotechnology companies and regulatory agencies evaluate the long-term stability of engineered genetic constructs, making him a key authority in this niche but vital area. Lovatt's research continues to underpin best practices for biosafety assessment, ensuring that innovative biotech products meet the highest standards of safety and efficacy.
Research Focus
Key Achievements
Top Papers
- 1